Gadolinium based MRI contrast agents
Prof. Terreno Enzo (Principal Investigator)
ActivitiesThe chemistry of Gd-complexes is one of the first research line which has been tackled at CIM. It starts from the synthesis of differently functionalized Gd-based probes and continues to their relaxometric characterization for the in-depth elucidation of the relationships between structure and dynamics of paramagnetic metal complexes and the determinants of their proton relaxation enhancement. Moreover, all the new Gd-complexes which are here synthetized and characterized are tested for their specific function in vitro (at the cellular level) and/or in vivo (in specific animal models). In recent years, a new concern came out on the use of Gadolinium-based contrast agents (GBCAs) in clinical settings as MRI contrast agents associated to the finding that small amounts of gadolinium are retained in the brain (and in other body districts) of patients who received multiple doses of GBCAs during their life. The intrinsic difficulties associated with the availability of human biopsies prompted the development of animal models to investigate Gd-retention in the brain. The study of the processes beyond Gd-retention issue has been object of a new research activity at CIM. |
Group
|
keyboard_arrow_down
Link a Iris del PI
keyboard_arrow_down
|